GlassScriptPhysician profile
Anne M Fitzpatrick
NPI 1598740516
$1,644.19
in general payments reported to CMS, 2019-2025
17 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $203 · 2021: $231 · 2022: $259 · 2023: $184 · 2024: $264 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.63 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $742.17 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $161.90 | 2019-2021 | |
| Allergan, INC. | $140.89 | 2019-2021 | |
| Sight Sciences, INC. | $92.55 | 2021-2022 | |
| Alcon Vision LLC | $87.97 | 2022-2025 | Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $81.50 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $68.82 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $58.88 | 2023-2025 | Vyzulta, Miebo |
| Novartis Pharmaceuticals Corporation | $43.43 | 2019 | |
| Kala Pharmaceuticals, INC. | $34.06 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $26.41 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $25.52 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Topcon Healthcare, INC. | $18.73 | 2025 | |
| Amgen INC. | $16.41 | 2025 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $13.03 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Fitzpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.